Article
Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.
Journal of diabetes and its complications - 1 Jan 2000
Sapkota Bishwa, Subramanian Anuradha, Priamvada Gargi, Finely Hadley, Blackett Piers R, Aston Christopher E, Sanghera Dharambir K
Abstract excerpt
BACKGROUND AND OBJECTIVES: Apolipoprotein E (APOE) gene polymorphisms have been examined extensively in multiple global populations particularly due to their crucial role in lipid metabolism and cardiovascular disease. However, the overall contribution of APOE polymorphisms in type 2 diabetes (T2D) and coronary artery disease (CAD) in South Asians is still under-investigated. The objectives of this investigation...
Topics
- Alleles
- Apolipoprotein E3
- Case-Control Studies
- Cohort Studies
- Coronary Artery Disease
- Diabetes Mellitus, Type 2
- Diabetic Angiopathies
- Drug Resistance
- Drug Therapy, Combination
